| 1 | Approve Financial Statements | For |
| 2 | Receive the Directors Report | For |
| 3 | Approve Non-Financial Statements | For |
| 4 | Discharge Corporate Management | Oppose |
| 5 | Amend Articles: Preliminary Title | For |
| 6 | Amend Articles: Articles 4 and 32 | For |
| 7 | Amend Articles: Article 8 | For |
| 8 | Approve the Dividend | For |
| 9 | Approve the Special Dividend | For |
| 10 | Authorise the Scrip Issue at a Market Value of EUR 2,275 million | For |
| 11 | Authorise the Scrip Issue at a Market Value of EUR 1,500 million | For |
| 12 | Reduce Share Capital | For |
| 13 | Approve the Remuneration Report | Abstain |
| 14 | Approve New Long Term Incentive Plan (2023-2025 Strategic Bonus) | Oppose |
| 15 | Elect Maria Helena Antolin Raybaud - Non-Executive Director | Oppose |
| 16 | Elect Armando MartÃnez MartÃnez - Chief Executive | For |
| 17 | Elect Manuel Moreu Munaiz - Non-Executive Director | Oppose |
| 18 | Elect Sara de la Rica Goiricelaya - Non-Executive Director | For |
| 19 | Elect Xabier Sagredo Ormaza - Non-Executive Director | Oppose |
| 20 | Elect Jose Ignacio Sanchez Galan - Chair (Executive) | Oppose |
| 21 | Set the Number of Board Directors | For |
| 22 | Delegation of powers to implement agreements adopted by shareholders at the general meeting | For |
